Stuart W. Peltz
2017
In 2017, Stuart W. Peltz earned a total compensation of $2.2M as Chief Executive Officer at PTC Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $302,357 |
|---|---|
| Option Awards | $974,423 |
| Salary | $636,540 |
| Stock Awards | $242,568 |
| Other | $16,795 |
| Total | $2,172,683 |
Peltz received $974.4K in option awards, accounting for 45% of the total pay in 2017.
Peltz also received $302.4K in non-equity incentive plan, $636.5K in salary, $242.6K in stock awards and $16.8K in other compensation.
Rankings
In 2017, Stuart W. Peltz's compensation ranked 5,120th out of 14,666 executives tracked by ExecPay. In other words, Peltz earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,120 out of 14,666 | 65th |
Division Manufacturing | 1,821 out of 5,770 | 68th |
Major group Chemicals And Allied Products | 541 out of 2,074 | 74th |
Industry group Drugs | 417 out of 1,730 | 76th |
Industry Pharmaceutical Preparations | 330 out of 1,329 | 75th |
Source: SEC filing on April 30, 2018.
Peltz's colleagues
We found six more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2017.
2017
Marcio Souza
PTC Therapeutics
Chief Operating Officer
2017
Mark Boulding
PTC Therapeutics
Chief Legal Officer
2017
Mark Rothera
PTC Therapeutics
Former Chief Commercial Officer
2017
Neil Almstead
PTC Therapeutics
Executive Vice President, Research, Pharmaceutical Operations & Technology
2017
Christine Utter
PTC Therapeutics
Principal Financial Officer and Treasurer
2017
Shane Kovacs
PTC Therapeutics